Ovarian cancer: a focus on management of recurrent disease

摘要: Surgery and chemotherapy form the cornerstone in treatment of ovarian cancer. The standard care for primary cancer is platinum taxane-based chemotherapy. Despite favorable response characteristics, however, most women with advanced-stage will relapse. Herzog Pothuri discuss options available highlight issues surrounding how these patients should be managed surgical, chemotherapy, biological targeted agents radiation therapy. Currently, Even among advanced suboptimal disease (i.e. tumors greater than 1 cm) following surgery, clinical efficacy noteworthy. relapse, including about 50% who have no evidence after A multitude are at time recurrence, but there clear consensus managed. Options include hormones, sometimes, sequence, combinations treatment, manner which any or all employed an individual patient, heretofore not been standardized, subjects ongoing investigations.